Earlier this week, the U.S. Senate passed the FDA Modernization Act 3.0, requiring the @fda.gov to update its regulations to replace references to “animal” testing with “nonclinical” methods. Learn more about how @greenstonebio.bsky.social is supporting this shift: www.linkedin.com/posts/greens...

We are 1 week away from the next entry in the @greenstonebio.bsky.social webinar series, featuring Dr. Mark Mercola, Professor at @stanfordmedicine.bsky.social and the Stanford Cardiovascular Institute Register here:https://us06web.zoom.us/webinar/register/WN_eZ2jB3SkQzOvrCW4b2CbzQ#/registration

We are 2 weeks away from the next entry in the @greenstonebio.bsky.social webinar series, featuring Dr. Mark Mercola, Professor at @stanfordmedicine.bsky.social and the Stanford Cardiovascular Institute Register here:https://us06web.zoom.us/webinar/register/WN_eZ2jB3SkQzOvrCW4b2CbzQ#/registration

Recently, the @fda.gov unveiled the Plausible Mechanism Pathway, a new approval route that lets some therapies gain authorization without traditional randomized controlled trials. Learn more about how @greenstonebio.bsky.social is supporting this shift here: www.linkedin.com/feed/update/...

We are excited to announce the newest entry in the @greenstonebio.bsky.social webinar series, featuring Dr. Mark Mercola, Professor of Medicine at @stanfordmedicine.bsky.social and Professor in the Stanford Cardiovascular Institute Register here: us06web.zoom.us/webinar/regi...

Our latest post in the @greenstonebio.bsky.social gut organoid series highlights how we support researchers in evaluating gastrointestinal (GI) toxicity using human-relevant in-vitro systems. Read more here: www.linkedin.com/feed/update/...

This week, the UK announced a plan to accelerate the transition toward NAMs. At @GreenstoneBio we already see human iPSC-derived systems are rapidly becoming essential tools for drug discovery and safety testing. Read more here: www.linkedin.com/feed/update/...

We’re thrilled to share that @greenstonebio.bsky.social is a proud sponsor of the 2026 Stanford Drug Discovery Symposium. This will be our third year sponsoring this event! You can join us and register for SDDS 2026 here: med.stanford.edu/cvi/events/s...

In case you missed it live, the newest @greenstonebio.bsky.social Webinar featuring Dr. William Pu, Professor of Pediatrics at @harvardmed.bsky.social is now available to watch for free online! Catch the full recording here: lnkd.in/gtTFeBjZ

We’re excited to announce that @greenstonebio.bsky.social is partnering with NVIDIA to accelerate drug discovery through the application of advanced AI foundational models, combining NVIDIA's computational power with our drug discovery methods. Read more: www.biopharmadive.com/press-releas...

Today is just one day away from the next installment of our Greenstone Biosciences webinar series, featuring Dr. William Pu. Professor of Pediatrics at @harvardmed.bsky.social on Tuesday, October 28th. Learn more: linkedin.com/posts/greens... Secure your spot: us06web.zoom.us/webinar/regi...

Greenstone Biosciences is partnering with Illumina to advance precision drug discovery. This collaboration combines Greenstone’s extensive iPSC biobank with Illumina’s cutting-edge single-cell and spatial genomics technologies. Read More: www.biopharmadive.com/press-releas...

Greenstone Bioscience's very own Director of the hiPSC Biobank, Dr Todd Herron, PhD, has co-authored a commentary in @nature.com: “Alternatives to animal testing are the future — it’s time that journals, funders and scientists embrace them.” Read it here: www.nature.com/articles/d41...

Tomorrow our biobank director Dr. Todd Herron will be speaking in the Cellular Insights Series: Innovations and Ethics in Stem Cell Research, presented by Wiley and @ascbiology.bsky.social Date: October 23, 2025 Time: 12:00 – 1:00 PM ET Sign up here: events.bizzabo.com/765090?utm_s...

We are now one week out from the next installment of our Greenstone Biosciences webinar series, featuring Dr. William Pu. Professor of Pediatrics at Harvard Medical School on Tuesday, October 28th. Learn more: linkedin.com/posts/greens... Secure your spot: us06web.zoom.us/webinar/regi...

We’re excited to share that Dr. Todd Herron, Director of our hiPSC Biobank, will be a featured speaker in the upcoming Cellular Insights Series: Innovations and Ethics in Stem Cell Research. Date: October 23, 2025 Time: 12:00 – 1:00 PM ET Sign up here: www.ascb.org/ascb-meeting...

We’re excited to announce that Greenstone Biosciences now offers comprehensive gut permeability assays to support drug discovery. These assays help evaluate: - Barrier dysfunction in disease models - Drug-induced effects on tight junctions - Restoration of barrier integrity

We’re proud to share a new publication resulting from a collaboration between Greenstone Biosciences and the Stanford Cardiovascular Institute, advancing the study of inherited cardiovascular disease. Read the full paper here: lnkd.in/g8djR-9H

We are excited to announce the next installment of our Greenstone Biosciences webinar series, featuring Dr. William Pu. Professor of Pediatrics at Harvard Medical School on Tuesday, October 28th. Learn more here: www.linkedin.com/posts/greens... Secure your spot: us06web.zoom.us/webinar/regi...

We’re proud to share that our co-founder, Joseph C. Wu, MD, PhD, will be a Keynote Lecturer at the 12th Annual Comprehensive Cardiovascular Center Symposium (CCVC) this October 9-10 in Birmingham, Alabama! Learn more about this years CCVC here: www.uab.edu/medicine/car...

We’re excited to discuss a new tool in our platform Greenstone: hiPSC-derived intestinal organoids. Greenstone has successfully reprogrammed iPSCs into intestinal organoids through two intermediate stages: endoderm and midgut. Learn more here: www.linkedin.com/feed/update/...

We’re excited to share a new publication in Circulation from Stanford Cardiovascular Institute, co-authored by Greenstone Scientists This study investigates the arrhythmia causing effects of fentanyl using hiPSCs and Mouse Models. Learn more here: www.linkedin.com/feed/update/...

We’re excited to highlight a new offering from Greenstone: chamber-specific 3D cardiac organoids. Each cryopreserved vial contains approximately 300 organoids, with more than 85% resuming spontaneous contractions after being thawed. Learn more here: www.linkedin.com/feed/update/...